BioCardia, Inc. Revenue from Contract with Customer, Including Assessed Tax
BioCardia, Inc. (BCDA) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-03-24
- BioCardia, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $0.00.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $0.00.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $58.00K, a 87.84% decline from fiscal 2023.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $477.00K, a 64.72% decline from fiscal 2022.
- BioCardia, Inc. revenue from contract with customer, including assessed tax for fiscal 2022 was $1.35M, a 33.20% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $0.00 10-K · filed 2026-03-24 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-06-30 | $0.00 10-Q/A · filed 2025-10-29 | $0.00 10-Q/A · filed 2025-10-29 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $0.00 derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $3.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $3.00K derived: sum of 3 quarters · filed 2026-03-24 | $58.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $3.00K derived: sum of 2 quarters · filed 2025-11-12 | $58.00K 10-Q · filed 2025-11-12 | $71.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $3.00K 10-Q/A · filed 2025-10-29 | $58.00K 10-Q/A · filed 2025-10-29 | $71.00K derived: sum of 3 quarters · filed 2025-10-29 | $428.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-03-31 | $55.00K 10-Q · filed 2025-05-14 | $68.00K derived: sum of 2 quarters · filed 2025-05-14 | $425.00K derived: sum of 3 quarters · filed 2025-05-14 | $468.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $370.00K derived: sum of 2 quarters · filed 2025-03-26 | $413.00K derived: sum of 3 quarters · filed 2025-03-26 | $477.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $357.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 2 quarters · filed 2024-11-13 | $464.00K 10-Q · filed 2024-11-13 | $570.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $43.00K 10-Q · filed 2024-08-13 | $107.00K 10-Q · filed 2024-08-13 | $213.00K derived: sum of 3 quarters · filed 2024-08-13 | $425.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $64.00K 10-Q · filed 2024-05-14 | $170.00K derived: sum of 2 quarters · filed 2024-05-14 | $382.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.36M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $318.00K derived: sum of 2 quarters · filed 2024-03-27 | $1.29M derived: sum of 3 quarters · filed 2024-03-27 | $1.35M 10-K · filed 2024-03-27 |
| 2022-09-30 | $212.00K 10-Q · filed 2023-11-08 | $1.19M derived: sum of 2 quarters · filed 2023-11-08 | $1.25M 10-Q · filed 2023-11-08 | $1.32M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $974.00K 10-Q · filed 2023-08-09 | $1.03M 10-Q · filed 2023-08-09 | $1.11M derived: sum of 3 quarters · filed 2023-08-09 | $1.93M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $60.00K 10-Q · filed 2023-05-10 | $139.00K derived: sum of 2 quarters · filed 2023-05-10 | $960.00K derived: sum of 3 quarters · filed 2023-05-10 | $1.03M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $900.00K derived: sum of 2 quarters · filed 2023-03-29 | $969.00K derived: sum of 3 quarters · filed 2023-03-29 | $1.01M 10-K · filed 2023-03-29 |
| 2021-09-30 | $821.00K 10-Q · filed 2022-11-09 | $890.00K derived: sum of 2 quarters · filed 2022-11-09 | $936.00K 10-Q · filed 2022-11-09 | $982.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $69.00K 10-Q · filed 2022-08-10 | $115.00K 10-Q · filed 2022-08-10 | $161.00K derived: sum of 3 quarters · filed 2022-08-10 | $195.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $46.00K 10-Q · filed 2022-05-11 | $92.00K derived: sum of 2 quarters · filed 2022-05-11 | $126.00K derived: sum of 3 quarters · filed 2022-05-11 | $153.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $80.00K derived: sum of 2 quarters · filed 2022-03-29 | $107.00K derived: sum of 3 quarters · filed 2022-03-29 | $145.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $34.00K 10-Q · filed 2021-11-10 | $61.00K derived: sum of 2 quarters · filed 2021-11-10 | $99.00K 10-Q · filed 2021-11-10 | $314.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $27.00K 10-Q · filed 2021-08-12 | $65.00K 10-Q · filed 2021-08-12 | $280.00K derived: sum of 3 quarters · filed 2021-08-12 | $474.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $38.00K 10-Q · filed 2021-05-13 | $253.00K derived: sum of 2 quarters · filed 2021-05-13 | $447.00K derived: sum of 3 quarters · filed 2021-05-13 | $533.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $409.00K derived: sum of 2 quarters · filed 2021-03-30 | $495.00K derived: sum of 3 quarters · filed 2021-03-30 | $710.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $194.00K 10-Q · filed 2020-11-10 | $280.00K derived: sum of 2 quarters · filed 2020-11-10 | $495.00K 10-Q · filed 2020-11-10 | $599.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $86.00K 10-Q · filed 2020-08-13 | $302.00K 10-Q · filed 2020-08-13 | $405.00K derived: sum of 3 quarters · filed 2020-08-13 | $489.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $216.00K 10-Q · filed 2020-05-15 | $319.00K derived: sum of 2 quarters · filed 2020-05-15 | $403.00K derived: sum of 3 quarters · filed 2020-05-15 | $642.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $187.00K derived: sum of 2 quarters · filed 2020-04-09 | $426.00K derived: sum of 3 quarters · filed 2020-04-09 | $625.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | $84.00K 10-Q · filed 2019-11-19 | $323.00K derived: sum of 2 quarters · filed 2019-11-19 | $522.00K 10-Q · filed 2019-11-19 | $622.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-06-30 | $239.00K 10-Q · filed 2019-08-14 | $438.00K 10-Q · filed 2019-08-14 | $538.00K derived: sum of 3 quarters · filed 2020-04-09 | $668.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-03-31 | $199.00K 10-Q · filed 2019-05-15 | $299.00K derived: sum of 2 quarters · filed 2020-04-09 | $429.00K derived: sum of 3 quarters · filed 2020-04-09 | $541.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $230.00K derived: sum of 2 quarters · filed 2020-04-09 | $342.00K derived: sum of 3 quarters · filed 2020-04-09 | $479.00K 10-K · filed 2020-04-09 |
| 2017-09-30 | $130.00K 10-Q · filed 2018-11-08 | $242.00K derived: sum of 2 quarters · filed 2018-11-08 | $379.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $112.00K 10-Q · filed 2018-08-09 | $249.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $137.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $576.00K 10-K · filed 2019-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |